Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, anew inhibitor of lipolysis-Reference-Cited by-同舟云学术

Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, anew inhibitor of lipolysis

Published:1981-02 Issue:3-4 Volume:38 Page:267-271
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Sirtori Cesare R.,Gianfranceschi Gemma,Sirtori Marina,Bernini Franco,Descovich Giancarlo,Montaguti Ubaldo,Fuccella Luciano M.,Musatti Lisa

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Fuccella, L.M., Goldaniga, G., Lovisolo, P.P., Maggi, E., Musatti, L., Mandelli, V. and Sirtori, C.R., Inhibition of lipolysis in man by nicotinic acid and acipimox, a new anti-lipolytic agent. Clin. Pharmacol. Ther., In press.

2. Preliminary results of acipimox treatment in hyperlipoproteinemias;Sirtori,1980

3. Classification of hyperlipidemias and hyperlipoproteinemias;Beaumont;Wld Hlth Org. Bull.,1970

4. Use of a single color reagent to improve the automated determination of serum cholesterol;Block,1965

5. Improved accuracy in the automated fluorometric determination of plasma triglycerides;Noble;Clin. Chem.,1971

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asipimoksun DPPC Model Membranlar Üzerindeki Etkilerinin Kalorimetrik İncelenmesi;Türk Tarım ve Doğa Bilimleri Dergisi;2023-07-23

2. NAD + homeostasis in human health and disease;EMBO Molecular Medicine;2021-05-27

3. The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential;Genes & Diseases;2021-04

4. NAD+ homeostasis in health and disease;Nature Metabolism;2020-01

5. Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases;Journal of Enzyme Inhibition and Medicinal Chemistry;2018-01-01